General MedicineOTC AvailablePregnancy Cat. Not classifiedFDA Yes
Naphazoline Hci And Pheniramine Maleate
NAPHAZOLINE HYDROCHLORIDE , PHENIRAMINE MALEATE
Uses: temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
Medically reviewed by MedCentralHub Medical Review Board, Licensed Pharmacists & Physicians ·
Brand names:Naphazoline HCI And Pheniramine Maleate
Quick Reference
Medicine ClassGeneral Medicine
FDA ApprovedYes
PregnancyCategory Not classified
Quick Facts
- Active ingredient
- NAPHAZOLINE HYDROCHLORIDE , PHENIRAMINE MALEATE
- Medicine class
- General Medicine
- Brand names
- Naphazoline HCI And Pheniramine Maleate
- Availability
- Over-the-counter (OTC)
- Pregnancy category
- Not classified
- FDA approved
- Yes
Medical Review
Medically reviewed- Reviewed by
- MedCentralHub Medical Review Board
- Credentials
- Licensed Pharmacists & Physicians
- Last reviewed
- Next review
Written from primary sources (FDA labeling, NIH/MedlinePlus, peer-reviewed literature) and verified by our review board. Educational information only — not a substitute for professional medical advice. See our medical disclaimer.
What Is Naphazoline Hci And Pheniramine Maleate?
Uses: temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
Naphazoline Hci And Pheniramine Maleate (NAPHAZOLINE HYDROCHLORIDE , PHENIRAMINE MALEATE) belongs to the General Medicine class of medications. It was first approved by the FDA in Yes. This medication is available over-the-counter without a prescription.
Key Safety Information
- •Always follow the dose recommended by your healthcare professional. Taking more than prescribed increases the risk of side effects including serious complications.
- •Seek emergency care if you experience signs of an allergic reaction — hives, swelling, difficulty breathing, or rash. Stop the medication and call your doctor immediately.
- •Some medications can increase the risk of cardiovascular events. Tell your doctor if you have high blood pressure, a history of heart attack or stroke, or any pre-existing health condition.
- •Avoid or limit alcohol while taking Naphazoline Hci And Pheniramine Maleate. Do not drink alcohol without first discussing it with your healthcare provider as it may increase adverse effects.
- •Take Naphazoline Hci And Pheniramine Maleate with food or a full glass of water if stomach upset occurs. Stop use and talk to your doctor if you experience persistent stomach pain or GI symptoms.
- •Tell your doctor about all medications, supplements, and vitamins you take. Some combinations significantly increase the risk of harm.
This is a summary only. Always read the full prescribing information and consult your healthcare provider for personalized medical advice.
Uses & Indications
Naphazoline Hci And Pheniramine Maleate is prescribed for the following conditions. Some uses are FDA-approved indications; others may be evidence-based off-label uses. Consult your healthcare provider for personalized guidance.
Uses: temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
Dosage Guide
The following are general dosing guidelines only. Your actual dose should be determined by your healthcare provider based on your condition, renal/hepatic function, and other medications.
AD
Adult Dosage
Directions: Adults and children 6 years of age and older: instill 1 or 2 drops in affected eye(s) up to 4 times daily. Children under 6 years: ask a doctor.
Available Forms
Available Strengths
Side Effects
Common
Serious
- Warnings: if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician.
- Do not use in children under 6 years of age unless directed by a physician.
- If this solution changes color or becomes cloudy, do not use.
- Overuse of this product may produce increased redness of the eye.
- If you are sensitive to any ingredient in this product, do not use.
Rare
Medicine Interactions
Always inform your healthcare provider and pharmacist about ALL medications you take, including prescriptions, OTC medicines, vitamins, and supplements.
MajorModerateMinor
Warnings & Contraindications
Warnings: if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician. Do not use in children under 6 years of age unless directed by a physician. If this solution changes color or becomes cloudy, do not use.
How Naphazoline Hci And Pheniramine Maleate Works
Pharmacokinetics
Pregnancy & Breastfeeding Safety
Not classified
Breastfeeding
Many medications pass into breast milk in varying amounts. Before using Naphazoline Hci And Pheniramine Maleatewhile breastfeeding, discuss the benefits and risks with your healthcare provider or pharmacist — they can weigh your dose, your infant's age, and available lactation safety data to find the safest option for you and your baby.
Storage & Handling
Store at room temperature 20 degrees - 25 degrees C ( 68 degrees - 77 degrees F). Protect from light.
Frequently Asked Questions
Related on MedCentralHub
- Class hub
General Medicine alternatives
Compare all General Medicine medications — uses, side effects, and cost differences
- Detail
Naphazoline Hci And Pheniramine Maleate dosage guide
Adult, pediatric, renal, and hepatic dosing for Naphazoline Hci And Pheniramine Maleate
- Detail
Naphazoline Hci And Pheniramine Maleate side effects
Complete adverse effect profile including common, serious, and rare reactions
- Topic
InteractGuard
- Topic
FDA Alerts & Recalls
- Topic
FDA Approvals
- Topic
Medicine Safety Guide
- Topic
Pregnancy Safety
- Topic
Pediatric Dosing
Sources & References
- • FDA Prescribing Information — Official labeling and package insert for Naphazoline Hci And Pheniramine Maleate
- • U.S. National Library of Medicine — MedlinePlus drug information
- • American Hospital Formulary Service (AHFS) — Clinical pharmacology monograph
- • PubMed / MEDLINE — View clinical studies
Last reviewed by MedCentralHub Medical Review Board · MedCentralHub Editorial Policy
Sources & References
Content on this page is drawn from the following primary sources and reviewed against current labeling.
- FDA DailyMed — Official FDA prescribing information and drug labels
- MedlinePlus (NIH) — Patient-friendly drug information from the National Library of Medicine
- FDA Drug Safety Communications — Current FDA safety alerts, recalls, and label changes
- PubMed — Peer-reviewed clinical literature
Medical Disclaimer
The information on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your doctor, pharmacist, or qualified healthcare provider before starting, stopping, or changing any medication.